Is Sanginita Chemi. overvalued or undervalued?
As of November 18, 2025, Sanginita Chemi is considered an attractive investment opportunity due to its undervalued metrics, including a low Price to Book Value of 0.50 and an EV to Sales ratio of 0.27, despite a concerning PE Ratio of -57.63 and a year-to-date return of -31.19%.
As of 18 November 2025, Sanginita Chemi's valuation grade has moved from very attractive to attractive. The company is currently considered undervalued, particularly given its low Price to Book Value of 0.50 and an EV to Sales ratio of 0.27, which are significantly below industry averages. However, the PE Ratio stands at -57.63, indicating potential concerns regarding profitability.In comparison with peers, Sanginita Chemi's metrics reveal a stark contrast; for instance, Solar Industries has a PE of 94.24 and an EV to EBITDA of 58.00, while Godrej Industries, categorized as attractive, has a PE of 37.03 and an EV to EBITDA of 40.62. Despite its recent stock performance lagging behind the Sensex, with a YTD return of -31.19% compared to the Sensex's 9.58%, the underlying valuation metrics suggest that Sanginita Chemi may present a buying opportunity for investors looking for value in the chemicals and petrochemicals sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
